Your browser doesn't support javascript.
loading
Sex differences in COVID-19 symptoms and outcomes in people with kidney failure treated with dialysis: a prospective cohort study.
Harrison, Tyrone G; Tam, Trinity A; Elliott, Meghan J; Ahmed, Sofia B; Riehl-Tonn, Victoria; Swamy, Asha K R; Benham, Jamie L; Peterson, Joanne; MacRae, Jennifer M.
Affiliation
  • Harrison TG; Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Tam TA; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
  • Elliott MJ; Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Ahmed SB; Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Riehl-Tonn V; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
  • Swamy AKR; Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Benham JL; Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Peterson J; Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • MacRae JM; Department of Medicine, University of Calgary, Calgary, AB, Canada.
J Nephrol ; 36(3): 851-860, 2023 04.
Article in En | MEDLINE | ID: mdl-36087218
ABSTRACT

BACKGROUND:

People with kidney failure treated with dialysis are at increased risk of SARS-CoV-2 infection, and severe COVID-19 outcomes such as hospitalization and death. Though there are well-defined sex differences in outcomes for the general population with COVID-19, we do not know whether this translates into kidney failure populations. We aimed to estimate the differences in COVID-19 symptoms and clinical outcomes between males and females treated with maintenance dialysis.

METHODS:

In this prospective observational cohort study, we included adults treated with maintenance dialysis in Southern Alberta, Canada that tested positive for COVID-19 between March 2020 and February 2022. We examined the association between sex (dichotomized as male and female) with COVID-19 symptoms including fever, cough, malaise, shortness of breath, muscle joints/aches, nausea and/or vomiting, loss of appetite, diarrhea, headache, sore throat, and loss of smell/taste using chi-square or Fisher's exact tests. Secondary outcomes included 30-day hospitalization, ICU admission, and death.

RESULTS:

Of 1,329 cohort participants, 246 (18.5%) tested positive for SARS-CoV-2 and were included in our study, including 95 females (39%). Of 207 participants with symptoms assessed, females had less frequent fever (p = 0.003), and more nausea or vomiting (p = 0.003) compared to males, after correction for multiple testing. Males exhibited no symptoms 25% of the time, compared with 10% of females (p = 0.01, not significant when corrected for multiple testing). We did not identify statistically significant differences in clinical outcomes between the sexes, though vaccinated patients had lower odds of hospitalization.

CONCLUSIONS:

Sex differences in COVID-19 symptoms were identified in a cohort of patients treated with maintenance dialysis, which may inform sex-specific screening strategies in dialysis units. Further work is necessary to examine mechanisms for identified sex differences.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Renal Insufficiency / COVID-19 Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: J Nephrol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Renal Insufficiency / COVID-19 Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: J Nephrol Year: 2023 Document type: Article